Adverse effects of hyperglycaemia, once thought an epiphenomenon in the pathogenesis of diabetic microworld, diabetes mellitus is the most prevalent cause of end-stage renal disease ( ESRD). Diabetic nephropathy and macrovascular complications, presently are a central focus of active clinical and basic investigation is as likely to develop in long-duration non-insulindependent diabetes (type 2) as in insulin-dependent [3]. For example, the US Diabetes Control and
Toxicity of glucose
Whereas initial formulations of how glucose might be Background toxic to tissues and organs were simplistic (Figure 2) , subsequently, an enormous literature documents the Registries of end-stage renal disease ( ESRD) in 1997, injurious consequences of complex protein-kinin-enin the US, Japan and industrialized Europe, show that zyme interactions stimulated by a high ambient plasma diabetes mellitus is the most prevalent cause of treated glucose concentration ( Figure 3 ). Based on observarenal failure world-wide. More than a decade previ-tional studies tying glycaemic control to proteinuria ously, Mauer and Chavers grasped the trend in ESRD and decline in glomerular filtration rate (GFR) plus demographics in stating that 'Diabetes is the most more than half a dozen interventive studies predicting important cause of ESRD in the Western world' [1] . and confirming the DCCT, it is established that hyperBoth the incidence and prevalence of diabetic ESRD glycaemia is the main metabolic perturbation causing patients have increased yearly over the past decade. irreversible kidney damage in diabetes. There are three Statistics for 1995, listed in the 1997 report of the candidate mechanisms to explain how hyperglycaemia United States Renal Data System ( USRDS), under-damages tissues [8]. PKC activity is increased in renal glomeruli, retina, aorta and heart of diabetic animals, probably because . The USRDS does not distinguish between type 1 and type 2 diabetes in their reporting forms. Registries in Europe and Japan also list diabetes as the disease accounting for the greatest number of incident and prevalent ESRD cases.
deposition of advanced glycosylated end-products (AGEs) [10] (discussed below).
Diabetes type in diabetic nephropathy
Dialysis patients in the US, Japan and Europe, whose ESRD is due to diabetes are predominantly type 2: <8% of diabetic Americans are insulinopenic, Cpeptide-negative persons who have type 1 diabetes. ESRD in diabetic persons reflects the demographics of diabetes per se [11] in that: (i) incidence [12] is greater in women, blacks [13] , hispanics [14] and native Americans [15] ; and (ii) peak incidence of ESRD with these attack rates is the reality that blacks over Advanced glycation end-products in diabetic nephropathy 3 the age of 65 years face a seven times greater risk of individuals for whom prophylactic coronary artery angioplasty or bypass surgery is likely to extend life diabetes-related renal failure than do whites. In the US, it is not surprising, therefore, that ESRD associ- [27] . A key additional member of the patient's protective team is a podiatrist who delivers routine foot care ated with diabetes is largely a disease of elderly blacks [16 ] . Recent surveys of Brooklyn city and state hospital while maintaining surveillance for risk of major lower extremity disease, thereby reducing sharply the chance ambulatory haemodialysis units in October 1997 discovered 97% of prevalent patients to have type 2 diabetes. of toe, foot and limb amputations [28] .
Orthostatic hypotension, gastropathy, cardiovasSeverity and duration of hyperglycaemia rather than diabetes type determine the extent of vasculopathic cular arrythymia [29] and cystopathy are frequently overlooked, highly prevalent co-morbid disorders that complications of diabetes [17, 18] . Unfortunately, however, neither the USRDS nor the European Dialysis plague the long-duration diabetic patient restricting life quality in ESRD. Additional expressions of autoand Transplant Association reports distinguish between type 1 and type 2 diabetes in terms of dialysis nomic neuropathy, e.g. obstipation and explosive night time diarrhoea, often co-exist with gastroparesis [30] . morbidity and mortality or post-transplant patient and allograft survival. Imprecise diabetes classification provokes confusing terms such as 'insulin requiring' to explain treatment with insulin in persons thought to Pregnancy have resistant type 2 diabetes. Present criteria are unable to classify as many as one-half of diabetic Pregnancy in diabetes complicated by kidney disease persons as type 1 or type 2 diabetes [19, 20] . (proteinuria and/or azotaemia), previously regarded as Observations in carefully followed type 2 diabetic an unavoidable prelude to disaster-inordinate fetal subjects contradict the common impression that type loss and/or maternal morbidity and death-can be 2 diabetes induces nephropathy relatively infrequently managed with a high probability of success. Detection [21] . Manifestations of nephropathy are remarkably of macroproteinuria, in the absence of urinary infecsimilar in the two main diabetes types [22] despite tion, in a type 1 pregnancy will be followed by predifferences in genetic predisposition [23] . Early nephro-eclampsia in 30-50%, though perinatal survival should megaly, as well as both glomerular hyperfiltration and exceed 95% [31] . Once the serum creatinine concentramicroalbuminuria, previously thought limited to type tion exceeds 2.0 mg/dl, diabetic women are counselled 1, are equally prevalent in type 2 [24] .
to avoid pregnancy. Facilitated by a satisfactory renal transplant, however, perinatal outcome can be 'excellent' despite a superimposed pre-eclamsia rate of
Co-morbid risk factors
20-40%. In 182 pregnant women with type 1 diabetes, 46 of whom had overt nephropathy for a minimum of Management of a diabetic person through progressive 3 years after delivery, pregnancy neither increases the renal insufficiency is more difficult than in age-and risk of subsequent nephropathy nor accelerates progender-matched non-diabetic persons because of gression of pre-existing renal disease [32] . An equally extensive, often life-threatening, extrarenal (co-encouraging series from Finland reported the course morbid) disease. Diabetic patients manifesting ESRD of 28 diabetic women for 7 years after delivery comsuffer an increased death rate compared with non-pared with 17 nulliparous controls matched for age, diabetic ESRD patients due to greater attack rates for duration of diabetes and severity of vasculopathy, cardiac decompensation, stroke, sepsis and pulmonary advising: 'pregnancy does not seem to affect developdisease ( Figure 4 ). Co-morbid disease ( Tables 1 and ment or progression of diabetic nephropathy' [33] . 2), especially blindness, limb amputations and cardiac disease, limits and may prevent rehabilitation. The difference between rehabilitation and invalidism in
The dilemma in selecting uraemia therapy diabetic ESRD patients depends on attaining a renal transplant. Restricted to dialytic treatment, the diabetic ESRD patient experiences an unending sequence of Suboptimal care is the rule in diabetic nephropathy in both Europe and the US, an inference discerned from complications, especially atherosclerotic heart disease and cerebrovascular catastrophes that induce a high defective attention to co-morbidity in symptomatic kidney patients. In Germany, for example: 'preterminal rate of withdrawal from therapy (a form of suicide) [25] (Figure 4) . care in diabetic patients with ESRD' is deficient in amount and quality [34] with inadequate attention to The threat of blindness, a dreaded complication at all times in every diabetic individual, is noted in the control of hypertension, hyperlipidaemia or ophthalmological intervention [35] . In the UK, at variance histories of laser treatment and/or vitrectomy for retinopathy elicited from >90% of diabetic individuals who with prior consensus, withdrawal from renal replacement therapy was not infrequent, accounting for 17% begin maintenance dialysis or receive a renal allograft. Comprehensive management [26 ] requires integration of all deaths, and was due mainly to co-morbid medical problems (89%) especially diabetic vasculopathy [36 ] . of laser and/or vitreous surgery. Repetitive heart evaluation, even in asymptomatic patients, including coron-Likewise, in the US, Ifudu et al. found that because of excessive co-morbidity: 'Few elderly, diabetic hemoary angiography (if indicated), is vital to detect those Haematological problems other than anaemia 10.
Spinal abnormalities, lower back problems or arthritis 11.
Vision impairment (minor to severe-decreased acuity to ESRD outcome blindness) loss 12.
Limb amputation (minor to severe-finger to lower extremity)
Maintenance haemodialysis is the only renal replace-13. Mental or emotional illness (neurosis, depression, psychosis) ment regimen that will be employed for >80% of diabetic persons who develop ESRD in the US.
To obtain a numerical co-morbidity index for an individual patient, Peritoneal dialysis is utilized for 12%, while only 8% rate each variable from 0 to 3 (0=absent, 1=mild-of minor import will receive a kidney transplant. Maintenance haemo-to patient's life, 2=moderate, 3=severe). By proportional hazard dialysis fails to restore vigour to diabetic patients, as analysis, the relative significance of each variable can be isolated documented by Lowder et al. (1986) , who found that from the other 12. of 232 diabetics on maintenance haemodialysis, only seven were employed while 64.9% were unable to conduct routine daily activities without assistance [38] . True, enthusiasts characterize continuous ambulatory peritoneal dialysis (CAPD) as 'a first choice treatment' Approximately 50% of US diabetic patients begun on maintenance haemodialysis die within 2 years of their for diabetic ESRD patients [39] . By contrast, Rubin et al., in a largely black diabetic population, reported first dialysis due to co-morbid complications, mainly sepsis, heart and cerebrovascular disease. Figure 5 that only 34% of their patients continued CAPD after 2 years and, at 3 years, only 18% remained on shows selected USRDS death rates by diagnosis in haemodialysis patients treated from 1993 to 1995 [2] . CAPD [40] .
Limited by unequal cohorts and physician bias, there Peritoneal dialysis is hardly different from haemodialysis in its high mortality and dismal rehabilitation. are no objective comparisons of either mortality or co- Fig. 5 . While strong selection bias in assigning treatment modality obviously skews the data, it is still remarkable to note the superior survival of kidney transplant recipients over those ESRD patients treated by dialysis. For this analysis, survival of peritoneal and haemodialysis patients was grouped. Note that within both transplant and dialysis subsets, diabetic patients had greater mortality than did non-diabetic patients. morbidity in diabetic patients treated by haemodialysis transplant, compared with dialytic therapy. It is the enhanced life quality permitted by a kidney transplant vs peritoneal dialysis. Illustrating this problem are reports from the CANUSA study that attempted com-that stimulates a strong preference for this ESRD option in newly evaluated diabetic persons with ESRD parative survival and other variables in CAPD patients in the US and Canada [41] . All results were unable to under the age of 60 years. Many 3-year survivors return to occupational, school and home responsibilitaccount for a much increased relative risk of death (1.93) in the US, perhaps a function of a 2-fold greater ies after a diabetic kidney transplant.
Applicable to no more than 9% of uraemic diabetic acceptance rate for ESRD that may have enrolled sicker (greater co-morbidity) patients. Data subsets patients who have type 1 diabetes, pancreatic transplantation is growing in acceptability and technical from the USRDS Report for 1997 [1] show that diabetic patients in all groups have a greater death risk success [45] . Global results in simultaneous kidneypancreas transplants show that >90% of recipients on CAPD than on haemodialysis. Also, peritoneal dialysis patients in the US had a 14% greater risk of were alive at 1 year, >80% had functioning kidney grafts, and >70% no longer required insulin [46 ] . hospitalization than did patients undergoing haemodialysis [42] . At variance with these findings, Fenton However, inserting a functioning pancreas will not impede progression or recurrence of diabetic nephroet al., using data from the Canadian Organ Replacement Register for 11 970 patients who began pathy. Unfortunately, pancreas transplantation in patients with extensive extrarenal disease has neither ESRD therapy between 1990 and 1994, concluded that peritoneal dialysis 'is not associated with increased arrested nor reversed diabetic retinopathy, diabetic cardiomyopathy or extensive peripheral vascular dismortality rates relative to hemodialysis' [43] . The decision to treat a diabetic patient with CAPD, there-ease [47, 48] . Consensus thinking is that the ESRD patient with type 1 diabetes should consider a simultanfore, must be individual-specific.
Provision of a kidney transplant is unquestionably eous kidney and pancreas transplant as at least a temporary cure of inexorable disease [49] . the best ESRD option in diabetes. In one centre, a retrospective review of all kidney transplants perFor unexplained reasons, Europe attains better survival of diabetic ESRD patients [50] than does the US formed between 1987 and 1993 noted no significant difference in actuarial 5-year patient or kidney graft [51] . An example of European excellence is recorded from the UK: in seven large renal units between 1983 survival between diabetic and non-diabetic recipients overall or when analysed by donor source. Nor was and 1985, patients starting CAPD or haemodialysis were monitored prospectively over 4 years. Of 610 any difference in mean serum creatinine at 5 years noted between diabetic and non-diabetic recipients diabetic and non-diabetic patients (median age 52 years, range 3-80 years) beginning CAPD and 329 [44] . The sharp superiority of survival following a kidney transplant when compared with peritoneal dia-patients (median age 48 years, range 5-77 years) starting haemodialysis, patient survival estimates at 4 lysis and haemodialysis is shown in Figure 6 extracted from the 1997 report of the USRDS [2]. Fewer than years were 74% for haemodialysis and 62% for CAPD [52] . Only 8% of the study population had diabetes, five in 100 diabetic ESRD patients treated by dialysis live for 10 years, while cadaver donor and living donor however. Dialyser reuse and shortened treatment hours in the US have been incriminated as promoting fatal kidney allograft recipients fare far better. Rehabilitation is incomparably better following a renal underdialysis [53] . On the other hand, rebutting the allegation that US dialysis mortality is higher than enzymatic reaction between ambient glucose and primthat in Europe, it is argued that because the US has ary amino groups on proteins to form glycated residues approximately twice the incidence of ESRD acceptance called Amadori products. These Amadori products are than Europe, older and sicker patients in the US then transformed to stable covalent adducts called obviously will experience greater mortality [54] .
advanced glycosylation end-products (AGEs) by a series of dehydration and fragmentation reactions. Hyperglycaemia in diabetes accelerates synthesis and Rehabilitation tissue deposition of AGEs, an abnormality contributing to the pathogenesis of co-morbid complications Pragmatic inferences from assessment of rehabilitation [59] . Orally absorbed AGEs from common foods in diabetic ESRD patients include: (i) participation in prepared routinely may impose an additional threat to structuring treatment is beneficial and (ii) renal trans-the diabetic individual with reduced kidney function plantation permits markedly superior rehabilitation [60] . Dietary restriction of AGE food intake may be than the best attainable result employing either periton-clinically applicable, though no trials have been eal dialysis or haemodialysis. In fairness to dialysis, performed. however, unless patient cohorts (haemodialysis vs AGEs are bound to a cell surface receptor (RAGE ) CAPD vs renal transplantation vs combined kidney inducing expression of vascular cell adhesion moleculeand pancreas transplantation) have equivalent co-1 ( VCAM-1), an endothelial cell surface cell-cell morbidity, conclusions about modality effect on outrecognition protein that can prime diabetic vasculature come are liable to be erroneous. We periodically inventfor enhanced interaction with circulating monocytes, ory co-morbid problems as a co-morbid index utilizing thereby initiating vascular injury [61] . Co-localization the Karnofsky scoring system [55] to assess patient of AGE and RAGE was found in experimental diabetes well being [56 ] . Gutman et al. in the 1970s who applied in the intima, media and adventitia of the aorta and the Karnofsky scoring to 2481 dialysis patients found the inner limiting membrane of the retina and nerve that diabetic patients achieved abysmal rehabilitation; bundles from mesenteric arteries [62] , a finding sugonly 23% of diabetic patients (vs 60% of non-diabetic gesting that ligand-receptor interaction may be importpatients) could perform physical activity beyond caring ant in the genesis of diabetic complications. for themselves [58] . A decade later, Lowder et al. reported equally poor rehabilitation in diabetic haemodialysis patients [33] . 
What are AGEs
to that of creatinine. Renal clearance of AGE-peptides is 0.72±0.23 ml/min for normal subjects and 0.61±0.2 ml for diabetics with normal glomerular filIn humans, ageing is associated with the Maillard reaction in which protein alteration results from a non-tration (P-value NS) [63] . A positive correlation Advanced glycation end-products in diabetic nephropathy 7 between mean serum AGEs and progression of diabetic leakage, while having opposite effects on histamine [75] . By blocking non-enzymatic glycosylation [76 ] , nephropathy by kidney biopsy underscores the probable toxicity of AGEs [64] . Diabetic uraemic patients aminoguanidine reduces AGE concentrations in the streptozotocin-induced diabetic rat. In rats made diaaccumulate AGEs in 'toxic' amounts that are not decreased to normal by haemodialysis or peritoneal betic, aminoguanidine: (i) prevents development of cataracts, (ii) prevents AGE accumulation (measured dialysis [65] . Accumulation of AGEs in the human diabetic kidney begins in arterial walls and with depos-by tissue fluorescence) in glomeruli and renal tubules and lessens glomerular basement membrane thickenition in nodular and exudative lesions in glomeruli [66 ] . After successful kidney transplantation, within ing, (iii) reduces severity of experimental diabetic retinopathy [77] , (iv) blocks development of the 'stiff 8 h of restoration of half-normal glomerular filtration, the plasma concentration of AGEs falls sharply [67] . myocardium' that is a main component of diabetic cardiomyopathy [78] ; and (v) stops diabetes-induced We hypothesize from the forgoing, that the higher mortality of peritoneal dialysis and haemodialysis-24% impairment in maximal endothelium-dependent relaxation to acetylcholine for phenylephrine-pretreated diabetic patients compared with those given a renal transplant results from, at least in part, AGE contracted aortas [79] .
The strategic potential of blocking AGE formation toxicity. A multicentre trial of aminoguanidine in diabetic haemodialysis patients was initiated in 1996 to impede development of diabetic complications has been reviewed [80, 81] . An attractive aspect to decreasto test this hypothesis.
Linkage between hyperglycaemia, hyperlipidaemia, ing AGE production as a means of impeding diabetic complications is the elimination of the necessity for nitric oxide activity and atherosclerosis in the pathogenesis of diabetic complications is highly probable. euglycaemia [82] uraemia [68] . It has been shown that LDL modified ing neurotransmission [69] , wound healing [70] and [2105] [2106] [2107] [2108] [2109] [2110] blood flow in small vessels [71] . Thus, AGEs, by Those actions of nitric oxide that may be pertinent to 9. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, nephrologists have been reviewed [73] .
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